Malcolm N. Palfreyman

607 total citations
20 papers, 482 citations indexed

About

Malcolm N. Palfreyman is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Malcolm N. Palfreyman has authored 20 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Malcolm N. Palfreyman's work include Synthesis and Biological Activity (5 papers), Phosphodiesterase function and regulation (4 papers) and Synthesis and Catalytic Reactions (3 papers). Malcolm N. Palfreyman is often cited by papers focused on Synthesis and Biological Activity (5 papers), Phosphodiesterase function and regulation (4 papers) and Synthesis and Catalytic Reactions (3 papers). Malcolm N. Palfreyman collaborates with scholars based in United Kingdom, United States and Puerto Rico. Malcolm N. Palfreyman's co-authors include John E. Souness, Jan‐Anders Karlsson, David Raeburn, Michael J. Ashton, Richard J. Stoodley, Karen Ebsworth, Miriam Griffin, Kenneth H. Pollock, David Cook and Nigel Vicker and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Tetrahedron.

In The Last Decade

Malcolm N. Palfreyman

20 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm N. Palfreyman United Kingdom 10 322 195 149 92 86 20 482
Frederick Wong United States 11 212 0.7× 179 0.9× 58 0.4× 47 0.5× 84 1.0× 18 456
Sung-Eun Yoo South Korea 12 265 0.8× 279 1.4× 52 0.3× 72 0.8× 39 0.5× 22 664
Lluı́s Pagès Spain 13 288 0.9× 253 1.3× 56 0.4× 27 0.3× 109 1.3× 17 496
Ermengilda McCauley United States 9 117 0.4× 66 0.3× 123 0.8× 92 1.0× 104 1.2× 11 382
Tai Wei Ly Taiwan 13 139 0.4× 178 0.9× 49 0.3× 83 0.9× 42 0.5× 26 435
James R. Pruitt United States 16 197 0.6× 284 1.5× 51 0.3× 42 0.5× 171 2.0× 22 700
Paul A. Tuthill United States 9 167 0.5× 149 0.8× 54 0.4× 55 0.6× 21 0.2× 14 371
Edward J. Kusner United States 10 120 0.4× 65 0.3× 68 0.5× 209 2.3× 89 1.0× 15 402
Bernd Jablonka Germany 7 159 0.5× 233 1.2× 34 0.2× 61 0.7× 23 0.3× 14 508
Gregory R. Luedtke United States 11 158 0.5× 253 1.3× 48 0.3× 54 0.6× 27 0.3× 15 425

Countries citing papers authored by Malcolm N. Palfreyman

Since Specialization
Citations

This map shows the geographic impact of Malcolm N. Palfreyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm N. Palfreyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm N. Palfreyman more than expected).

Fields of papers citing papers by Malcolm N. Palfreyman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm N. Palfreyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm N. Palfreyman. The network helps show where Malcolm N. Palfreyman may publish in the future.

Co-authorship network of co-authors of Malcolm N. Palfreyman

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm N. Palfreyman. A scholar is included among the top collaborators of Malcolm N. Palfreyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm N. Palfreyman. Malcolm N. Palfreyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Souness, John E., Miriam Griffin, Karen Ebsworth, et al.. (1996). Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer. British Journal of Pharmacology. 118(3). 649–658. 104 indexed citations
2.
Palfreyman, Malcolm N. & John E. Souness. (1996). 1 Phosphodiesterase Type IV Inhibitors. Progress in medicinal chemistry. 33. 1–52. 43 indexed citations
3.
Webber, Stephen E., Martyn Foster, David Raeburn, et al.. (1995). Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP‐specific phosphodiesterase: comparison with rolipram. British Journal of Pharmacology. 115(1). 39–46. 69 indexed citations
4.
Palfreyman, Malcolm N.. (1995). Phosphodiesterase type IV inhibitors as antiinflammatory agents. Drugs of the Future. 20(8). 793–793. 29 indexed citations
5.
Ashton, Michael J., David Cook, Garry Fenton, et al.. (1994). Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs. Journal of Medicinal Chemistry. 37(11). 1696–1703. 93 indexed citations
6.
7.
Brown, Thomas J., Robert F. Chapman, Jonathan Mason, et al.. (1993). Syntheses and biological activities of potent potassium channel openers derived from (.+-.)-2-oxo-1-pyridin-3-yl-cyclohexanecarbothioic acid methylamide: new potassium channel openers. Journal of Medicinal Chemistry. 36(11). 1604–1612. 6 indexed citations
8.
Brown, Thomas J., Robert F. Chapman, David Cook, et al.. (1992). Synthesis and biological activity of trans-(.+-.)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (RP 49356) and analogs: a new class of potassium channel opener. Journal of Medicinal Chemistry. 35(20). 3613–3624. 33 indexed citations
9.
Stoodley, Richard J., et al.. (1984). Studies related to cyclopentanoid natural products. Part 3. Synthesis of pentenomycin and its racemate. Journal of the Chemical Society Perkin Transactions 1. 2089–2089. 21 indexed citations
10.
Elliott, John D., et al.. (1983). Syntheses of (±)- and (−)-pentenomycin I. Tetrahedron Letters. 24(9). 965–968. 11 indexed citations
11.
Elliott, John D., et al.. (1983). Studies related to cyclopentanoid natural products. Part 2. An improved route to (4R)-4-hydroxy-2-hydroxymethylcyclopent-2-en-1-one and its O-substituted derivatives. Journal of the Chemical Society Perkin Transactions 1. 2441–2441. 11 indexed citations
12.
Banerjee, Arnab, et al.. (1981). Synthesis and anti-ulcer activity of 16-phenoxy analogues of (+)-11-deoxyprostaglandin E1. Prostaglandins. 22(2). 167–182. 6 indexed citations
13.
Elliott, John D., et al.. (1981). Studies related to cyclopentanoid natural products. Part 1. Preparation of (4RS)- and (4R)-4-hydroxy-2-hydroxymethylcyclopent-2-en-1-one; a versatile synthetic intermediate. Journal of the Chemical Society Perkin Transactions 1. 1782–1782. 20 indexed citations
14.
Elliott, John D., et al.. (1980). 4-Hydroxy-2-hydroxymethylcyclopent-2-en-1-one: a versatile intermediate for the synthesis of cyclopentanoid natural products. Journal of the Chemical Society Chemical Communications. 924–924. 3 indexed citations
15.
Palfreyman, Malcolm N., et al.. (1980). Synthesis and antifertility activity of ω-chain phenyl- and 16-phenoxy-analogues of (±)-11-deoxyprostaglandin F1α. Prostaglandins. 19(4). 559–575. 5 indexed citations
16.
Ansell, M. F., et al.. (1979). Synthesis of structure analogues of thromboxane A2. Tetrahedron Letters. 20(46). 4497–4498. 7 indexed citations
17.
Palfreyman, Malcolm N., et al.. (1974). Potential chemotherapeutic agents. Formation of 2,7-naphthyridones from nicotinamide derivatives. Journal of the Chemical Society Perkin Transactions 1. 1. 57–57. 5 indexed citations
18.
Dyke, S.F., et al.. (1971). 1,2-Dihydroisoquinolines—XVI. Tetrahedron. 27(2). 281–289. 6 indexed citations
19.
Brown, David W., S.F. Dyke, Malcolm N. Palfreyman, & M. Sainsbury. (1968). The influence of acids on 4-benzyl-1,2-dihydroisoquinoline derivatives. Tetrahedron Letters. 9(54). 5615–5618. 1 indexed citations
20.
Dyke, S.F., et al.. (1968). 1,2-dihydroisoquinolines—IX. Tetrahedron. 24(23). 6703–6717. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frederick Wong Breakdown of academic impact, for papers by Sung-Eun Yoo Breakdown of academic impact, for papers by Lluı́s Pagès Breakdown of academic impact, for papers by Ermengilda McCauley Breakdown of academic impact, for papers by Tai Wei Ly Breakdown of academic impact, for papers by James R. Pruitt Breakdown of academic impact, for papers by Paul A. Tuthill Breakdown of academic impact, for papers by Edward J. Kusner Breakdown of academic impact, for papers by Bernd Jablonka Breakdown of academic impact, for papers by Gregory R. Luedtke
Rankless by CCL
2026